FDA.reportPublic FDA data

tazarotene 0.1 % Topical Gel

RxCUI
313201
RxNorm name
tazarotene 0.1 % Topical Gel
Display name
tazarotene 0.1 % Topical Gel
Full name
tazarotene 0.1 % Topical Gel
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:14

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
TrilitasTAZAROTENEPerfero Pharma, Inc.1cf1faef-73b8-4ab2-a4c8-521f0bd3fc102026-05-18Warnings, Adverse reactionsExact identifier
rxcui: 313201
TazoracTAZAROTENEAlmirall, LLC4e4e4b81-420e-4492-8a74-80b692a800572025-11-13Warnings, Adverse reactionsExact identifier
rxcui: 313201
TazaroteneTAZAROTENESolaris Pharma Corporationf1c98c4a-f101-4f3c-851a-39c827415c462025-01-02Warnings, Adverse reactionsExact identifier
rxcui: 313201
TAZAROTENETAZAROTENEBryant Ranch Prepackaa6fff2f-01c7-4669-be67-07cec82c768a2024-05-29Warnings, Adverse reactionsExact identifier
rxcui: 313201
TAZAROTENETAZAROTENEPadagis Israel Pharmaceuticals Ltdffd11dee-4266-4201-9573-1e82c2d30a632024-01-01Warnings, Adverse reactionsExact identifier
rxcui: 313201
TAZAROTENETAZAROTENECosette Pharmaceuticals, Inc.94749b8e-0d00-4257-a660-6d0fc8815fcf2023-11-29Warnings, Adverse reactionsExact identifier
rxcui: 313201

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 5 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
aa6fff2f-01c7-4669-be67-07cec82c768atazarotene 0.1 % Topical Gel [PSN] · tazarotene 0.001 MG/MG Topical Gel [SCD] · tazarotene 0.1 % Topical Gel [SY]3101These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 199720240529
4e4e4b81-420e-4492-8a74-80b692a80057tazarotene 0.1 % Topical Gel [PSN] · tazarotene 0.001 MG/MG Topical Gel [SCD] · tazarotene 0.1 % Topical Gel [SY]34These highlights do not include all the information needed to use TAZORAC ® Gel safely and effectively. See full prescribing information for TAZORAC ® Gel. TAZORAC ® (tazarotene) gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 199720251113
f1c98c4a-f101-4f3c-851a-39c827415c46tazarotene 0.1 % Topical Gel [PSN] · tazarotene 0.001 MG/MG Topical Gel [SCD] · tazarotene 0.1 % Topical Gel [SY]34These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 199720250102
ffd11dee-4266-4201-9573-1e82c2d30a63tazarotene 0.1 % Topical Gel [PSN] · tazarotene 0.001 MG/MG Topical Gel [SCD] · tazarotene 0.1 % Topical Gel [SY]33These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.05% and 0.1%, for topical use Initial U.S. Approval: 199720240101
94749b8e-0d00-4257-a660-6d0fc8815fcftazarotene 0.1 % Topical Gel [PSN] · tazarotene 0.001 MG/MG Topical Gel [SCD] · tazarotene 0.1 % Topical Gel [SY]32These highlights do not include all the information needed to use TAZAROTENE GEL safely and effectively. See full prescribing information for TAZAROTENE GEL. TAZAROTENE gel, 0.1%, for topical use Initial U.S. Approval: 199720231129